Evan Seigerman
Evan Seigerman is a biopharma specialist at BMO, known for his insights into the pharmaceutical sector. Recently, he revised the revenue forecast for Merck's Gardasil vaccine due to declining demand, highlighting the challenges that the company faces in regaining investor trust amid market fluctuations.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Canada | 1 | 9.00 | 0.09% | +0% | 38,005,238 | 35,552 | $1,700,000 | 1,590$ |
| Totals | 1 | 38,005,238 | 35,552 | $1,700,000 | 1,590$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
Evan Seigerman, managing director and head of healthcare research at BMO Capital Markets in New York, commented on the growing market for weight-loss and diabetes drugs.
9
United States:
Evan Seigerman, a financial analyst, anticipates that doctors and patients may turn to pills for weight maintenance.
6
United States:
Evan Seigerman sought to assuage investor fears of coming price cuts in a research note.
5
Slovenia:
Evan Seigerman illustrated the importance of real-world usage for such medications.
6
United States:
Evan Seigerman, senior biopharma analyst at BMO Capital Markets, commented on pharmaceutical companies' commitments.
5
Belarus:
Analyst Evan Seigerman from BMO Capital Markets believes Eli Lilly, as an American company, better understood the nuances of the US market.
6
Guyana:
Evan Seigerman, analyst at BMO Capital Markets, noted that implementing something like this is pretty challenging.
5
Guyana:
Evan Seigerman, analyst at BMO Capital Markets, mentioned that implementing something like this is pretty challenging.
5
Canada:
Evan Seigerman, a BMO Capital Markets analyst, commented on the tolerable profile of orforglipron.
7
United States:
Evan Seigerman, a pharmaceuticals analyst with BMO Capital Markets, wrote that the industry is not expected to make any major changes.
5